MONIPOL | Clinical Research

Founded in 1995, MONIPOL | Clinical Research is an owner-led CRO with German and Polish roots and strong regional partnerships across Europe. Leveraging over 25 years of experience in monitoring and organizing multicenter clinical trials, MONIPOL is committed to tailored solutions for the various needs of biotechnology and small/midsize pharma companies, to support them in bringing new and innovative therapies to market. MONIPOL's offering includes the conduct of Phase I-IV clinical trials in a wide range of therapeutic areas, with a particular focus on early-phase studies.